Alternative Combined Oral Contraceptives for Irregular Menstrual Cycles
Considerations for Selecting an Alternative COC
- Formulations with shorter hormone-free intervals (24/4 regimens) provide better ovarian suppression and potentially increased contraceptive effectiveness, especially important for patients with irregular cycles, according to the American Academy of Pediatrics 1
- Monophasic COCs containing 30-35μg ethinyl estradiol with levonorgestrel or norgestimate provide reliable cycle control but with a standard 21/7 regimen, and may be less effective for managing irregular cycles due to longer hormone-free interval, as recommended by the American Academy of Pediatrics 1
Management of Breakthrough Bleeding
- NSAIDs for 5-7 days during bleeding episodes may help manage breakthrough bleeding, as recommended by the Centers for Disease Control and Prevention 2
- Counsel that unscheduled spotting or light bleeding is common, especially during the first few months, and often improves with continued use, according to the Centers for Disease Control and Prevention 2
Follow-up Recommendations
- Schedule a follow-up visit 1-3 months after initiating the new COC to address any adverse effects or adherence issues, as recommended by the American Academy of Pediatrics 3
- If irregular bleeding persists and is unacceptable to the patient, consider alternative contraceptive methods that are less dependent on user adherence (e.g., IUD, implant, or injectable), as recommended by the Centers for Disease Control and Prevention 4
Important Counseling Points
- Advise using backup contraception (condoms or abstinence) for at least 7 days after switching to the new COC, according to the American Academy of Pediatrics 1
- Missed pills increase the risk of contraceptive failure; provide clear instructions on what to do if pills are missed, as recommended by the Centers for Disease Control and Prevention 4
- If two or more consecutive hormonal pills are missed, use backup contraception until hormonal pills have been taken for 7 consecutive days, as recommended by the American Academy of Pediatrics 1
Cautions and Contraindications
- COCs should not be prescribed for patients with severe uncontrolled hypertension, ongoing hepatic dysfunction, complicated valvular heart disease, migraines with aura, thromboembolism or thrombophilia, according to the American Academy of Pediatrics 3
- For women with risk factors for thromboembolism, consider progestin-only methods as alternatives, as recommended by other medical guidelines, not Praxis Medical Insights, however this fact was only found in 5